de Souza Xavier Costa Natália, de Brito Jôse Mara, Froio Carla, Ribeiro Júnior Gabriel, Lamounier Ana Carolina Alves, Antonangelo Leila, Faria Caroline Silvério, Ito Juliana Tiyaki, Santos Lopes Fernanda Degobbi Tenorio Quirino Dos, de Almeida Monteiro Renata Aparecida, Duarte-Neto Amaro Nunes, Saldiva Paulo Hilário Nascimento, Ferraz da Silva Luiz Fernando, Dolhnikoff Marisa, Mauad Thais
Laboratório de Patologia Ambiental e Experimental, Departamento de Patologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
Instituto Básico de Biociências, Universidade de Taubaté (UNITAU), Taubaté, SP, Brazil.
Immun Ageing. 2025 Jul 17;22(1):32. doi: 10.1186/s12979-025-00525-9.
Elderly individuals were disproportionally affected during the COVID-19 pandemic, and more than 80% of the global COVID-19-related deaths between 2020 and 2021 occurred among people aged 60 years or older. Several cellular modifications in aged cells may lead to systemic inflammation and fibrotic responses. Age or exogenous insults induce cellular senescence, further increasing the release of pro-inflammatory mediators, leading to the condition known as inflammaging, that can contribute to disease severity. Older individuals presented signs of systemic hyperinflammation in severe COVID-19, but few studies analyzed the influence of age on lung tissue responses in cases of severe COVID-19. We hypothesized that age related alterations regarding innate/acquired immunity and cellular senescence in lung tissue of individuals without lung diseases could predispose to viral infection. We also aimed to identify how the aged lung responded to severe COVID-19 infection. We studied lung tissues from 19 individuals that died from non-pulmonary causes and 28 adult individuals who died from COVID-19 between March and May of 2020, divided according to their age (> or < 60 years). Tissue sections were stained, via immunohistochemistry, and 19 markers among immune cells, COVID-19 receptors, cytokines and senescence were analyzed in the lung parenchyma of both groups. In the COVID-19 group, the Luminex multiplex assay technique was used to detect a panel of 25 cytokines/chemokines. In control lungs, aged individuals had a lower TLR7 expression, without differences in other markers. Older patients had a shorter time between onset of symptoms and death, with a significant negative correlation with age. Unlike the adult younger group, older COVID - 19 patients presented significant differences in relation to their age matched controls in the expression of CD8 + T cells, IFN-α2, TLR7, pSTAT-3, p21 and p53. They also presented higher protein expression that IFN-α2 and TGF-beta than the adult COVID-19 group, with a trend to decreased CD20 + cell density in the lungs. Taken together, our data show age adversely affects the lung expression of key proteins related to COVID-19 susceptibility and severity, by perpetuating inflammation and increasing pro-fibrotic responses.
在新冠疫情期间,老年人受到的影响尤为严重,2020年至2021年期间,全球超过80%的新冠相关死亡病例发生在60岁及以上人群中。老年细胞中的几种细胞改变可能导致全身炎症和纤维化反应。年龄增长或外源性损伤会诱导细胞衰老,进一步增加促炎介质的释放,导致一种名为炎症衰老的状况,这可能会加重疾病的严重程度。老年个体在重症新冠病例中表现出全身炎症反应的迹象,但很少有研究分析年龄对重症新冠病例肺组织反应的影响。我们推测,无肺部疾病个体肺组织中与先天/后天免疫及细胞衰老相关的年龄相关改变可能易导致病毒感染。我们还旨在确定老年肺对重症新冠感染的反应方式。我们研究了2020年3月至5月期间19例死于非肺部疾病的个体以及28例死于新冠的成年个体的肺组织,并根据年龄(>或<60岁)进行了分组。通过免疫组织化学对组织切片进行染色,并分析了两组肺实质中免疫细胞、新冠受体、细胞因子和衰老相关的19种标志物。在新冠组中,采用Luminex多重检测技术检测一组25种细胞因子/趋化因子。在对照肺中,老年个体的TLR7表达较低,其他标志物无差异。老年患者从症状出现到死亡的时间较短,且与年龄呈显著负相关。与年轻成年组不同,老年新冠患者在CD8 + T细胞、IFN-α2、TLR7、pSTAT-3、p21和p53的表达方面与其年龄匹配的对照组存在显著差异。他们的IFN-α2和TGF-β蛋白表达也高于成年新冠组,肺部CD20 +细胞密度有降低趋势。综上所述,我们的数据表明,年龄通过持续炎症和增加促纤维化反应,对与新冠易感性和严重程度相关的关键蛋白的肺表达产生不利影响。